A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment

Table 1

Demographic information of all participants.

Group	sMCI ()	pMCI ()	value
Sex (M/F)	136/106	102/76	0.89^a
Age (year)			0.004^b
Education (year)			0.496^c
MMSE			<0.001^b
CDRSB	1 (0.5,1.5)	1.5 (1, 2.5)	<0.001^c
ADAS11			<0.001^b
ADAS13			<0.001^b
Conversion time (month)	\		\
APOE ε4 positive rate	44.6%	68.5%	<0.001^a

Data are given as . : the chi-square test; : the two-sample -test; P^c: the Wilcoxon rank-sum test. MMSE: Mini-Mental State Examination; CDRSB: Clinical Dementia Rating Sum of Boxes; ADAS11: The Alzheimer’s Disease Assessment Scale with 11 tasks; ADAS13: The Alzheimer’s Disease Assessment Scale with 13 tasks; APOE ε4 positive rate: positive or negative for the presence of at least one ε4 allele.